SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,808 | -34.8% | 2,250 | -12.6% | 0.01% | -33.3% |
| Q2 2023 | $11,974 | +0.6% | 2,575 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $11,897 | -45.0% | 2,575 | -3.7% | 0.01% | -43.8% |
| Q4 2022 | $21,614 | -1.8% | 2,675 | -32.7% | 0.02% | -15.8% |
| Q3 2022 | $22,000 | -8.3% | 3,975 | -13.1% | 0.02% | 0.0% |
| Q2 2022 | $24,000 | -36.8% | 4,575 | 0.0% | 0.02% | -24.0% |
| Q1 2022 | $38,000 | -44.1% | 4,575 | 0.0% | 0.02% | -41.9% |
| Q4 2021 | $68,000 | -35.8% | 4,575 | -18.4% | 0.04% | -44.9% |
| Q3 2021 | $106,000 | +3.9% | 5,608 | +2.6% | 0.08% | +4.0% |
| Q2 2021 | $102,000 | +251.7% | 5,466 | +325.4% | 0.08% | +226.1% |
| Q1 2021 | $29,000 | +93.3% | 1,285 | +87.3% | 0.02% | +76.9% |
| Q4 2020 | $15,000 | – | 686 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |